Comparing outcomes after tricuspid valve repair for seniors
Part of Heart & circulation clinical trials.
This study looks at older adults with severe tricuspid regurgitation (a leaky heart valve) who either had a repair procedure with the PASCAL Precision system or received medication only. It helps us understand which approach may work better for people over 65.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older and enrolled in Medicare.
- You have severe tricuspid regurgitation, which means your heart valve leaks a lot of blood backward.
- You have either had the PASCAL Precision procedure done, or you have been treated with medication, but you have not had any other heart valve procedure (like surgery or a catheter-based repair).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study tests if a less invasive tricuspid valve repair or replacement can protect kidney function and improve physical activity in older adults with severe tricuspid valve leakage.
This study looks at what happens to adults with moderate-to-severe or severe tricuspid valve “leaking” after different treatment types, such as catheter-based or surgery. It may help doctors understand which approach works best for people with severe valve leakage and symptoms.
This trial tests a new device called Laplace TTVR to replace a leaky tricuspid valve in the heart without open surgery. It is for people with severe symptoms despite medical treatment.
This study is collecting information about people with severe tricuspid regurgitation (a leaky heart valve) who are having a catheter-based repair. The goal is to better understand these patients and how well the procedure works for them.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.